Archive for the ‘research’ Category

Psychosis, Serious Side-Effect of COVID Shot. Many May Be Suffering From ‘Delusion of Benefit’ Says Cardiologist

https://twitter.com/DrAseemMalhotra/status/1650031510328692737  Video Here (Approx. 9 Min)

Psychosis: Serous Side Effect of COVID Shot

Re-analysis of mRNA vaccine data suggests one serious side effect is Psychosis.  Many people who took the jab may be suffering from ‘delusion of benefit’ says cardiologist Dr. Aseem Malhotra
Overwhelming evidence to be presented in court that jab is ‘not safe & NOT effective.’
“In my whole career in medicine, Neil, with all the academic work I’ve done looking at all different areas of medicine, specifically also related to cardiovascular disease, I have never seen such high, overwhelming quality of evidence of harm of any drug and such poor efficacy,” ~ Dr. Aseem Malhotra
_________________
 2022 May; 71: 103129.
Published online 2022 Apr 13. doi: 10.1016/j.ajp.2022.103129
PMCID: PMC9006421
PMID: 35447503

Psychiatric adverse reactions to COVID-19 vaccines: A rapid review of published case reports

Ilambaridhi Balasubramanian, Abdul Faheem, Susanta Kumar Padhy,1 and Vikas Menon2,⁎
Author information Article notes Copyright and License information Disclaimer

Abstract

We aimed to review the available reports of psychiatric adverse reactions to COVID vaccines. Electronic databases such as PubMed and Google scholar were combed to identify relevant reports. We found a total of 11 reports describing 14 cases of psychiatric reactions; these were mostly altered mental states, psychosis, mania, depression, and functional neurological disorder. The index case was commonly a young or middle-aged adult. All reports pertained to the use of either mRNA or vector-based vaccines. Symptom onset was within 10 days of vaccination in all cases; as such, this seems to be a high-risk period warranting vigilance.

  • One month after getting the mRNA-based COVID injection and then worsening three weeks later after getting the 2nd dose, a 31 year old man without a past medical or psychiatric history was brought to the ER because of erratic and bizarre behavior.  He was anxious, guarded, superficial and grandiose, reported becoming ‘clairvoyant’, being able to talk to dead people, hearing ‘people drumming outside his house’ and the constant voice of a co-worker whom he believed to be a lover (but was not).
  • Patient after 2nd dose of COVID injection immediately developed anxiety, nonspecific fear, and insomnia as the prodromal phase of psychosis. Starting the second week, patient manifested delusions of persecution, delusions of influence, thoughts insertion, and delusional behavior, culminating in a suicide attempt.  Psychosis lasted 8 weeks and symptom reduction was observed only after the graduate administration of antipsychotics over four weeks.
  • 12 other case reports of psychosis after COVID shots.
  • Doctor censured for suggesting “vaccine” psychosis led husband to murder wife.

https://theconversation.com/post-covid-psychosis-occurs-in-people-with-no-prior-history-the-risk-is-low-but-episodes-are-frightening-179193

Post-COVID psychosis occurs in people with no prior history. The risk is low but episodes are frightening

By Sarah Hellewell, Research Fellow, Faculty of Health Sciences, Curtin University

Far from the respiratory disease it seemed at first, COVID can impact almost all parts of the body, including the brain. For a small number of people, COVID infection may be accompanied by an episode of post-COVID psychosis, a break from reality which can be frightening for the patient and their loved ones.

Psychosis is a condition characterised by confused thoughts, delusions and hallucinations. People with psychosis can struggle to tell what’s real from what isn’t. Psychosis occurs in “episodes” which may last for days or weeks. Since the start of the COVID pandemic, reports of post-COVID psychosis have come from all over the world.

Post-COVID psychosis is different to psychosis seen in other brain illnesses and diseases. So-called “first episode psychosis” is usually seen in teens or young adults in the development of schizophrenia, or alongside dementia in elderly people.

But people experiencing post-COVID psychosis are typically in their 30s, 40s and 50s, and are experiencing psychosis for the first time. They usually do not have any family history of psychosis. People with post-COVID psychosis also frequently have insight into the way they are feeling. They can recognise this is not normal for them, and something has changed in the way they are thinking.  (See link for article)

_______________

**Comment**

According to the article there were reports of post-viral psychosis during the Spanish flu as well as after the coronaviruses SARS and MERS.

This topic interests me as I experienced psychosis first-hand.  What a wild ride that was.  The event occurred while taking disulfiram/Antabuse, a new treatment at the time for Lyme disease and potentially Babesia.  If you are interested in that story, go here:

I attempt to highlight everything I can about the incident due to worries about single patients trying this treatment.  If you are single and live alone, you need to be checked on daily.  The psychosis can come on fast and you don’t know you are going nuts.  And you do go nuts.

Which brings me to Dr. Malhotra’s suggestion of ‘delusion of benefit’ theory.  I’m truly not trying to be divisive or mean here.  What I am attempting to do is point out that a perfect scenario was created in the past three years that could affect people’s reasoning ability: 

  1. Many had their faces covered for extended periods of time with oxygen depriving, CO2, and bacteria promoting toxic masks that science continues to show do nothing beneficial.
  2. Graphene, which is a toxic carcinogen, has been found in masks, PCR swabs, and the gene therapy injections. Symptoms caused by graphene are similar to COVID symptoms, further mudding the water of what a COVID case truly is since testing is fraudulently worthless.
  3. Graphene oxide in rats not only down-regulates glutamatergic synapses but changes synaptic function which is crucial to learning and memory. These changes are implicated in several brain diseases from dementia to anxiety disorders.
  4. Typically, these same people were then injected a graphene laced gene therapy with a known psychosis side effect that is linked to more reports of adverse reactions and death than any other vaccine in the history of VAERS.
  5. Multiple contaminants including metals have been found in the gene therapy.
  6. The gene therapy utilizes modified RNA (modRNA) forcing healthy cells to produce a toxic viral spike protein that disrupts cell metabolism, increases permeability of the blood-brain barrier, goes systemically into the body interfering with DNA repair, and is designed to persist – possibly forever.
  7. Another injection side-effect is blood clotting which will slow blood flow to the brain. One doctor found microclotting in over 60% of his vaxxed patients.
  8. Paxlovid, an “approved” yet ineffective treatment for COVID also can cause blood clotting.
  9. While authorities blame ‘climate change,’ these same authorities are spraying the air, and testing has confirmed graphene is in our precipitation along with a long list of toxins including aluminum particles, a known neurotoxin, which are found virtually everywhere from our food and body products to vaccines to cookware, which accumulate in the brain and are linked with Alzheimer’s, MS, asthma, autism, and autoimmune psychosis.
What a brilliantly orchestrated, or highly coincidental plan to affect the public’s ability to think and reason.
Food for thought.

Category:

Psychological Aspects, research, vaccines, Viruses

Mask Wearers Have Higher Rates of Infection, Critical Care, ER, Mental Disorder, Neuron Destruction, Anxiety, Death, Impaired Learning & Memory

https://www.bbc.com/news/uk-wales-65358308?at_medium=RSS&at_campaign=KARANGA

Covid: No evidence shielding helped – Swansea uni study

April 22, 2023
Woman looking out of window
GETTY IMAGES
The study says further research is needed to fully evaluate the success of shielding

There is no evidence that shielding benefited vulnerable people during the Covid pandemic, according to a study.

Swansea University compared 117,000 people shielding in Wales with the rest of the population of three million.

The study found deaths and healthcare usage were higher among shielding people than the general population.

The Welsh government said shielding was introduced on medical and scientific advice and it will continue to review evidence from the pandemic.

The study also found the Covid rate was higher among those shielding – 5.9% compared to 5.7%.

The researchers said the data raised questions about whether the policy worked.

(See link for article)
____________________
Important excerpt:

“It was sort of made up at the time and implemented.”

Truer words were never spoken.

Study found here:  https://www.sciencedirect.com/science/article/pii/S0033350623000628?via%3Dihub

_________________

German Mask Study: Masks Do Not Prevent Viral Infections But Carry Harm

  • Humans are normally exposed to .04% CO2.  Mask wearers are exposed to 1.41-3.2% CO2, demonstrating toxicity.
  • A thorough review of current studies on mask efficacy shows there has never been solid data to show makes prevent viral transmission.
  • The medical community has long since known about the dangers of prolonged CO2 exposure. 

Study here:  https://www.cell.com/heliyon/pdf/S2405-8440(23)01324-5.pdf

Possible toxicity of chronic carbon dioxide exposure associated with face mask use, particularly in pregnant women, children and adolescents – A scoping review

Kai Kisielinski a,* , Susanne Wagner b , Oliver Hirsch c , Bernd Klosterhalfen d , Andreas Prescher e a Independent Researcher, Surgeon, Private Practice, 40212 Düsseldorf, Germany b Non Clinical Expert, Veterinarian, Wagner MSL Management, 15831 Mahlow, Germany c Department of Psychology, FOM University of Applied Sciences, 57078 Siegen, Germany d Institute of Pathology, Dueren Hospital, 52351 Dueren, Germany e Institute of Molecular and Cellular Anatomy (MOCA), 52074 Aachen, Germany

ABSTRACT

Introduction: During the SARS-CoV-2-pandemic, face masks have become one of the most important ubiquitous factors affecting human breathing. It increases the resistance and dead space volume leading to a re-breathing of CO2. So far, this phenomenon and possible implications on early life has not been evaluated in depth.

Method: As part of a scoping review, literature was systematically reviewed regarding CO2 exposure and facemask use.

Results: Fresh air has around 0.04% CO2, while wearing masks more than 5 min bears a possible chronic exposure to carbon dioxide of 1.41% to 3.2% of the inhaled air. Although the buildup is usually within the short-term exposure limits, long-term exceedances and consequences must be considered due to experimental data. US Navy toxicity experts set the exposure limits for submarines carrying a female crew to 0.8% CO2 based on animal studies which indicated an increased risk for stillbirths. Additionally, mammals who were chronically exposed to 0.3% CO2 the experimental data demonstrate a teratogenicity with irreversible neuron damage in the offspring, reduced spatial learning caused by brainstem neuron apoptosis and reduced circulating levels of the insulin-like growth factor-1. With significant impact on three readout parameters (morphological, functional, marker) this chronic 0.3% CO2 exposure has to be defined as being toxic. Additional data exists on the exposure of chronic 0.3% CO2 in adolescent mammals causing neuron destruction, which includes less activity, increased anxiety and impaired learning and memory. There is also data indicating testicular toxicity in adolescents at CO2 inhalation concentrations above 0.5%.

Discussion: There is a possible negative impact risk by imposing extended mask mandates especially for vulnerable subgroups. Circumstantial evidence exists that extended mask use may be related to current observations of stillbirths and to reduced verbal motor and overall cognitive performance in children born during the pandemic. A need exists to reconsider mask mandates.

_________________

**Comment**

Yet, people continue to wear the face-diapers, and corrupt public health ‘authorities’ continue to insist, despite all reason, logic, and science, that they somehow work:  https://madisonarealymesupportgroup.com/2023/02/10/walensky-face-plants-again-but-is-still-in-office/

  • When questioned over the known harm masks have caused children and adults, CDC Director Rochelle Walensky doubled down on the mantra that masks prevent transmission, despite a meta-analysis on 78 studies by Cochrane that determined masks probably make little to no difference in the outcome of influenza-like illnesses like COVID.The analysis also reported: “Harms were rarely measured and poorly reported.”  
    • Go here for a “must read” article on how despite the good scholarship of the mask review, Cochrane has become nothing more than a “political junk science rag.” Within the article is a rare interview with Tom Jefferson, one of the study authors, who doesn’t trust the media (gee I wonder why?).  Jefferson states: “Governments completely failed to do the right thing and demand better evidence.”  I highly recommend reading the transcript as Jefferson highlights the shenanigans within science journals that will do virtually anything nowadays to publish the “right answer,” i.e. accepted answer for the accepted narrative.
    • In this important video, Dr. Prasad reads a statement from CDC director Rochelle Walensky and then states the following:

      “She’s just making things up.  She’s good at making things up. She made up the fact that there’s credible data that we should mask kids between 2 and 5 even though UNICEF and the WHO said not to do that. She made that up.  She makes up lots of things, because she doesn’t actually use science to guide decision making, she just likes to make things up.” ~ Dr. Vinay Prasad  

  • While health “authorities” try and cover their backsides and excuse their incompetence and/or evil intent by stating they had to do something other than wait around for “the science,” a Cochrane study author states it best:

“…it’s a complete subversion of the ‘precautionary principle’ which states that you should do nothing unless you have reasonable evidence that benefits outweigh the harms.”  ~ Tom Jefferson, Cochrane epidemiologist

But here we still are……

For more:

Category:

Activism, research, Viruses

Shape-Shifting Antibiotics?

https://www.pnas.org/doi/10.1073/pnas.2208737120

Shapeshifting bullvalene-linked vancomycin dimers as effective antibiotics against multidrug-resistant gram-positive bacteria

Alessandra Ottonello https://orcid.org/0000-0003-2133-2533, Jessica A. Wyllie, Oussama Yahiaoui, and John E. Moses https://orcid.org/0000-0003-2162-3234 moses@cshl.eduAuthors Info & Affiliations
Edited by Kyriacos Nicolaou, Rice University, Houston, TX; received May 20, 2022; accepted February 24, 2023
April 3, 2023
120 (15) e2208737120
https://doi.org/10.1073/pnas.2208737120
Abstract
The alarming rise in superbugs that are resistant to drugs of last resort, including vancomycin-resistant enterococci and staphylococci, has become a significant global health hazard. Here, we report the click chemistry synthesis of an unprecedented class of shapeshifting vancomycin dimers (SVDs) that display potent activity against bacteria that are resistant to the parent drug, including the ESKAPE pathogens, vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), as well as vancomycin-resistant S. aureus (VRSA). The shapeshifting modality of the dimers is powered by a triazole-linked bullvalene core, exploiting the dynamic covalent rearrangements of the fluxional carbon cage and creating ligands with the capacity to inhibit bacterial cell wall biosynthesis. The new shapeshifting antibiotics are not disadvantaged by the common mechanism of vancomycin resistance resulting from the alteration of the C-terminal dipeptide with the corresponding d-Ala-d-Lac depsipeptide. Further, evidence suggests that the shapeshifting ligands destabilize the complex formed between the flippase MurJ and lipid II, implying the potential for a new mode of action for polyvalent glycopeptides. The SVDs show little propensity for acquired resistance by enterococci, suggesting that this new class of shapeshifting antibiotic will display durable antimicrobial activity not prone to rapidly acquired clinical resistance.

Category:

research, Treatment

CPAC Warns: Lyme Risk Higher Than Ever

https://www.lymedisease.org/capc-parasite-forecast-2023/

CAPC warns that Lyme disease risk is higher than ever

April 20, 2023

The nonprofit Companion Animal Parasite Council (CAPC) — the nation’s leading source on parasitic diseases that threaten the health of pets and people — is warning that the risk of Lyme disease is higher than ever.

In its 2023 Parasite Forecast, CAPC documents how the blacklegged ticks that spread Lyme disease are expanding into new geographical areas. This increases the risk of Lyme disease outside of historically endemic places like the Northeast and Upper Midwest.

Parasite infections are real and can be harmful and even deadly to pets and people. Lyme disease is a predominant One Health issue, an approach calling for the collaborative efforts of multiple disciplines working to attain optimal health for animals, people and the environment.

11 years of forecasts

“Because of the zoonotic potential of pathogens like Lyme disease, we started providing annual forecasts eleven years ago to alert communities about the risks they pose to people and pets,” says Dr. Christopher Carpenter, DVM, and Chief Executive Officer of CAPC.

“Lyme disease, in particular, is an important One Health pathogen that occurs in both veterinary and human medical settings. CAPC’s Pet Parasite Forecast is critical to alerting pet owners, veterinarians and physicians to the risks this year and reinforcing CAPC’s recommendation that all pets need to be annually tested and protected year-round.”

In its 2023 annual forecast, CAPC reports the risk of acquiring Lyme disease in 2023 is elevated due to the expansive nature of the blacklegged tick vector (Ixodes scapularis).

This increase in Lyme prevalence can be attributed to land use, human population growth, urbanization, and changes in wildlife host density and location. Risks have also increased due to rehoming of pets, as well as changes in:

  • Distribution and prevalence of vector (tick) populations
  • Shifting wildlife populations and their infiltration into newly developed and reclaimed areas
  • Short- and long-term changes in climatic conditions
  • Changes in habitat due to natural or human-induced processes

Lyme Disease Forecast

For 2023, CAPC predicts Lyme disease is a high threat and continues to expand southward and westward outside of the historically high-risk areas in the Northeast and Upper Midwest, including Wisconsin, Minnesota and the upper peninsula of Michigan.

There is a higher-than-average seroprevalence predicted in northeastern Tennessee, western Michigan and Ohio, with high-risk “hot spots” expected in northwestern and southwestern Michigan, and southern and northeastern Ohio.

A higher-than-normal risk is also expected in North Dakota, northeastern South Dakota, Iowa, Illinois, and eastern Kentucky. The southward movement of Lyme is evident in the increasing risk in the Carolinas and Tennessee.

In addition, CAPC reports a northern expansion into Canada, including southern regions of Ontario, Quebec and Manitoba, as well as on New Brunswick and Nova Scotia, due to increased Lyme detection in Canadian dogs. Pets living in or traveling to these areas are considered at high risk.

Testing and Prevention Strategies

The 2023 forecasts – supported by ongoing research by parasitologists and statisticians in leading academic institutions across the United States – highlight areas where more should be done to lower the risk of companion animals’ exposure to disease vectors, such as ticks.

The foundation of these prevention strategies are recommendations that veterinarians and pet owners test their pets annually for disease and protect their pets with products that kill or repel ticks year-round.

A vaccination for Lyme disease should always be considered for pets in high-risk areas. Lyme disease, in particular, is an important One Health pathogen that impacts the health of both pets and people.

Veterinarians play an important role in preventing zoonotic disease in pets, as well as people, by implementing effective parasite control programs. In regions with historically high prevalence and in forecasted regions of increased risk, veterinarians should reinforce their recommendations of aggressive tick control.

CAPC One Health Study

Research conducted by CAPC underscores the value of CAPC’s prevalence maps and emphasizes the importance of a One Health approach to tick-borne diseases. In 2019, a CAPC study confirmed dogs safeguard humans serving as sentinels to alert humans where they are at greatest risk for tick-borne Lyme disease.

“With dogs being tested annually for exposure to the pathogen that causes Lyme disease, we were able to study over seven years of nationwide canine diagnostic data, representing more than 16 million data points — something difficult to achieve when studying ticks and the environment directly. And unlike the challenges with access to human medical records, anonymous veterinary data does not have these privacy concerns,” said Dr. Michael Yabsley, a CAPC Board Member and professor in the Department of Population Health, College of Veterinary Medicine and Warnell School of Forestry and Natural Resources at the University of Georgia.

Results from the study – “Quantifying the relationship between human Lyme disease and Borrelia burgdorferi exposure in domestic dogs” – published in the prestigious, peer-reviewed Geospatial Health quantified the relationship between incidences of tick exposure in domestic dogs to human Lyme disease. The model established in this research broke new ground by giving residents, travelers and health care providers a county-level map to help them identify areas of high Lyme risk across the country.

“By combining sophisticated statistical modeling with this invaluable canine data, we’re enabling veterinary medicine to benefit human medicine,” said Dr. Stella Self, assistant professor in the Department of Epidemiology and Biostatistics at University of South Carolina. “This research represents the first step on the long road to developing a forecast for human Lyme disease.”

30-Day Forecast Maps for Pet Owners

Pet owners who want to monitor the activity in their county throughout the year have access to 30-Day Parasite Forecast Maps at http://www.petdiseasealerts.org. These maps, developed exclusively by CAPC, provide a local forecast for every county in the continental United States on a monthly basis. This free service helps to remind pet owners of the continuous risk in their area and the importance of annual parasite testing and year-round protection.

“Because tick-borne diseases like Lyme are ever-changing, the 30-Day Pet Parasite forecasts at http://www.petdiseasealerts.org are an invaluable tool to protect both pets and people with monthly updates that show the risk for Lyme disease in their area,” said Dr. Rick Marrinson, Past President/Board Member for CAPC and owner of Longwood Veterinary Clinic in Longwood, Florida.

Other Parasite Spread in 2023

In addition to Lyme disease, CAPC forecasts that heartworm disease, which is transmitted by mosquitoes, and tick-borne diseases ehrlichiosis and anaplasmosis, continue to spread throughout the United States in 2023. Veterinarians and pet owners are encouraged to discuss how to effectively address the increased prevalence. Annual testing and year-round use of preventive products remains the best means of providing comprehensive parasite control and disease prevention.

How the Forecasts are Created

The annual CAPC Pet Parasite Forecasts are a collaborative effort between parasitologists and statisticians in leading academic institutions across the United States. These scientists engage in ongoing research and data interpretation to better understand and monitor vector-borne disease agent transmission and changing life cycles of parasites. The forecasts are based on many factors, including temperature, precipitation, and population density.

About the Companion Animal Parasite Council

The Companion Animal Parasite Council is an independent not-for-profit foundation comprised of parasitologists, veterinarians, as well as medical, public health and other professionals, who provide information for the optimal control of internal and external parasites that threaten the health of pets and people.

Formed in 2002, CAPC works to help veterinary professionals and pet owners develop the best practices in parasite management that protect pets from parasitic infections and reduce the risk of zoonotic parasite transmission.

SOURCE OF PRESS RELEASE: The Companion Animal Parasite Council 

Category:

Activism, Anaplasmosis, Ehrlichiosis, Lyme, research, Testing, Ticks

Cast Reports: Orbital Myositis Due to Lyme Disease

https://danielcameronmd.com/case-reports-orbital-myositis-due-to-lyme-disease/

CASE REPORTS: ORBITAL MYOSITIS DUE TO LYME DISEASE

myositis-lyme-disease

In their article “Two Cases of Orbital Myositis as a Rare Feature of Lyme Borreliosis,” Sauer et al. describe two female patients with focal orbital myositis due to Lyme disease. [1]

By 

Orbital myositis is typically caused by systemic disease, such as Grave’s disease, or haematological disorders like lymphomas, the authors explain. In these cases, myositis is often bilateral. It has been reported, as well, as a rare manifestation of Lyme disease.

In these two cases, myositis was confirmed by MRI findings.

Patient #1: 68-year-old female

“The 68-year-old patient had acute and recurrent episodes (lasting from 2 to 4 weeks, 2 to 4 times each year) of right orbital swelling and pain,” the authors wrote.

Each episode resolved spontaneously or with steroids and nonsteroidal anti-inflammatory drugs.

Lyme disease was suspected since the patient was living in a rural area of France, highly endemic for Lyme disease, and she recalled having numerous tick bites and had a history of an erythema migrans rash and arthralgia.

Testing for Lyme disease was positive and the woman began treatment with doxycycline. Within 3 weeks, her symptoms had resolved.

“We reported the cases of two patients who presented with orbital myositis caused by Borrelia infection.”

Patient #2: 13-year-old female

The 13-year-old adolescent complained about unilateral orbital swelling complicated with exophthalmia and horizontal diplopia.

“MRI showed a hyperintense signal of right inferior and medial rectus muscles,” the authors wrote.

The woman was living in an area endemic for Lyme disease and had a recent tick bite followed by an Erythema migrans rash.

Lyme disease testing was positive and she was treated successfully with 4 weeks of doxycycline.

The authors reported, “a resolution of ocular symptoms and a decrease of the MRI signal intensity were observed within 1 month.”

The authors conclude:

  • “Orbital myositis is an unusual manifestation of Lyme disease, although it is likely that the condition is underdiagnosed.”
  • “Unexplained muscle swelling occurring in a patient who has had a rash or a recent history of a tick bite in an endemic area for Lyme disease should prompt consideration of this diagnosis.”
Related Articles:

Lyme disease associated with eye problems

Growing list of eye problems in Lyme disease

Lyme disease causes vision loss in 46-year-old woman

References:
  1. Sauer A, Speeg-Schatz C, Hansmann Y. Two cases of orbital myositis as a rare feature of lyme borreliosis. Case Rep Infect Dis. 2011;2011:372470. doi: 10.1155/2011/372470. Epub 2011 Jul 28. PMID: 22567470; PMCID: PMC3336248.

________________

**Comment**

Where to even begin……

  1. Rarely reported is a far different matter than rarely occurs.  Everything about Lyme/MSIDS is downplayed. This most probably happens a lot.
  2. I hesitate to ponder what would have occurred if they hadn’t each tested positive, which is akin to winning the lottery with tests that miss 70% and in this case, 86% of cases.  Current 2-tiered CDC testing also completely omits testing for any coinfections which are quite common.
  3. The second patient had a tick-bite followed by the bullseye rash.  This proves she is infected with Lyme.  No testing required since the rash is diagnostic for Lyme – yet ‘the powers that be’ continue to take the deadly “wait and see” approach and continue to utilize faulty, inadequate testing for diagnosis and treatment.  It seems nothing ever changes.
  4. They continue to treat infected patients with the inadequate and limited mono-therapy of doxycycline, despite research and reality proving this doesn’t work.
  5. Like all other studies, these patients need lengthy follow-up.  IF that occurred, I guarantee that research would prove the current therapy simply doesn’t work.

For more on eye issues with Lyme/MSIDS:

Category:

Eye Issues, Lyme, research, Testing, Treatment